Document Detail

Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.
MedLine Citation:
PMID:  22188636     Owner:  NLM     Status:  MEDLINE    
Acute or destabilized heart failure (DHF) is characterized by new or worsening signs and symptoms of heart failure leading to admission to an emergency department. Biomarkers may support the diagnosis, the prognosis and the management of DHF patients. The aim of this review article is to discuss and evaluate the clinical usefulness of both recognized and potential new biomarker tests for use in heart failure.
Damien Gruson; Frédéric Thys; Franck Verschuren
Related Documents :
16125496 - Radiographic left ventricular-right ventricular interlead distance predicts the acute h...
12929296 - Cardiac resynchronization therapy: a new frontier in the management of heart failure.
20013626 - Pneumopericardium and pneumomediastinum as a late complication of defibrillator implant...
18325466 - Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial cont...
20692856 - Cardiac papillary fibroelastoma: source of cerebral embolism treated with intravenous t...
22457676 - Reduction in atherosclerotic events: a retrospective study in an outpatient cardiology ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Molecular diagnosis & therapy     Volume:  15     ISSN:  1179-2000     ISO Abbreviation:  Mol Diagn Ther     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-22     Completed Date:  2012-04-17     Revised Date:  2013-05-16    
Medline Journal Info:
Nlm Unique ID:  101264260     Medline TA:  Mol Diagn Ther     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  327-40     Citation Subset:  IM    
Pôle de Recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / metabolism*
Extracellular Matrix / metabolism
Heart Failure / diagnosis*,  metabolism
Inflammation / metabolism
Myocytes, Cardiac / metabolism,  pathology
Neurotransmitter Agents / metabolism
Oxidative Stress
Reg. No./Substance:
0/Biological Markers; 0/Neurotransmitter Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of biomarkers in clinical trials of Alzheimer disease: from concept to application.
Next Document:  Musculature Tissue Engineering to Repair Abdominal Wall Hernia.